NCT03755427View on ClinicalTrials.gov

A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

560

Participants

Timeline

Start Date

November 10, 2018

Primary Completion Date

January 5, 2019

Study Completion Date

November 15, 2019

Conditions
H7N9 Influenza
Interventions
BIOLOGICAL

15μg H7N9 Vaccine

The vaccine was a inactivated, whole virion preparation of the influenza A/Shanghai/2/2013(H7N9) virus, propagated in embryonated chicken eggs，mixed with aluminum hydroxide adjuvant.

BIOLOGICAL

Aluminum Hydroxide Adjuvant

The seasonal influenza vaccine was a inactivated, split virion preparation of the influenza virus, propagated in embryonated chicken eggs. The aluminum hydroxide adjuvant was 0.5ml aluminum hydroxide adjuvant.

Trial Locations (1)

463100

Suiping Center for Disease Control and Prevention, Zhumadian

All Listed Sponsors
lead

Shanghai Institute Of Biological Products

INDUSTRY

NCT03755427 - A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine | Biotech Hunter | Biotech Hunter